AsiaNet Daily Summary - Press Releases for Monday July 11, 2005

ข่าวต่างประเทศ Monday July 11, 2005 17:54 —Asianet Press Release

SYDNEY, July 11--AsiaNet/InfoQuest
SOYBEAN PLANT...
WHITE PLAINS: Bunge Limited has announced that it has agreed
to purchase a controlling interest in an integrated soybean
crushing and refining plant in the port city of Rizhao,
Shandong Province, China, from Sanwei Group Ltd. The plant,
Bunge's first in the country, will link Bunge directly to
customers in the expanding soybean meal and oil markets in the
Shandong region.
http://www.bunge.com
ABBOTT STATEMENT...
SAO PAULO: Abbott has announced that it achieved its goals
in negotiating an agreement with the government of Brazil
regarding Kaletra (lopinavir/ritonavir), the leading protease
inhibitor. The agreement accomplishes Abbott's objectives of
helping Brazil expand patient access to Kaletra while
preserving the company's intellectual property rights, which
Abbott was not willing to negotiate.
http://www.abbott.com
http://www.kaletra.com
UPGRADED RATING...
RIO DE JANEIRO: Companhia Vale do Rio Doce informs that
Moody's Investors Service (Moody's), one of the largest and
most prestigious rating agencies in the world, has announced
its decision to upgrade CVRD's foreign currency rating from Ba1
to Baa3. According to Moody's rating scale, Baa3 qualifies the
Company as a moderate credit risk issuer, without speculative
elements, corresponding to investment grade.
http://www.cvrd.com.br
FANNIE MAE...
WASHINGTON, D.C.: Fannie Mae will redeem the principal
amount of MTN securities issues amounting to a total of US$335
million on July 18, 19 and 20, 2005 at a redemption price equal
to 100 per cent of the principal amount redeemed plus accrued
interest. Fannie Mae will also redeem the principal amount of
UBEN securities issues amounting to a total of US$2 billion on
July 18, 2005 at a redemption price equal to 100 per cent of
the principal amount redeemed plus accrued interest.
http://www.fanniemae.com
PANACEA PHARMACEUTICALS...
GAITHERSBURG: Panacea Pharmaceuticals, Inc., a company
focused on developing therapeutic and diagnostic products for
cancer, has announced that it has closed its Series C Private
Placement raising approximately $7 million. Participants in the
round included Mitsubishi Corporation Life Sciences Venture,
Olympus, JSR, Shin-Etsu Chemical, Fuji Photo Film, Dai Nippon
Printing and Tokio Marine & Nichido Fire Insurance, among
others.
http://www.panaceapharma.com
http://www.CosmosAlliance.com
(AsiaNet is a consortium of leading news agencies
distributing unedited, translated news releases for worldwide
clients. Visit www.asianetnews.net for full-text versions.)

แท็ก access   China   asian   TOT   tat  

เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ